×
About 163,248 results

ALLMedicine™ Colorectal Cancer Center

Research & Reviews  77,055 results

Albumin-stabilized layered double hydroxide nanoparticles synergised combination chemot...
https://doi.org/10.1016/j.nano.2021.102369
Nanomedicine : Nanotechnology, Biology, and Medicine; Li L, Qian Y et. al.

Feb 26th, 2021 - Combination chemotherapy with two or more complimentary drugs has been widely used for clinical cancer treatment. However, the efficacy and side effects of combination chemotherapy still remains a challenge. Here, we constructed an albumin-stabili...

Sarcopenic obesity is a postoperative prognostic factor for stage II and III colorectal...
https://doi.org/10.1007/s11605-021-04965-8 10.1097/SLA.0000000000002555 10.1245/s10434-017-6077-y 10.1016/j.nut.2016.04.003 10.2169/internalmedicine.50.5474 10.1007/s10620-018-5019-2
Journal of Gastrointestinal Surgery : Official Journal Of... Mizuno S, Seishima R et. al.

Feb 26th, 2021 - Sarcopenic obesity is a postoperative prognostic factor for stage II and III colorectal cancer.|2021|Mizuno S,Seishima R,Okabayashi K,Shigeta K,Matsui S,|

see more →

Guidelines  419 results

Clinical Implications of colorectal cancer stem cells in the age of single-cell OMICs a...
https://doi.org/10.1053/j.gastro.2020.12.080
Gastroenterology Frank MH, Wilson BJ et. al.

Feb 22nd, 2021 - The cancer stem cell (CSC) concept emerged from the recognition of inherent tumor heterogeneity and suggests that within a given tumor, in analogy to normal tissues, there exists a cellular hierarchy composed of a minority of more primitive cells ...

Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recom...
https://doi.org/10.1016/j.gie.2020.09.039
Gastrointestinal Endoscopy; Shaukat A, Kaltenbach T et. al.

Nov 8th, 2020 - Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.|2020|Shaukat A,Kaltenbach T,Dominitz JA,Robertson DJ,Anderson JC,|

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
https://gut.bmj.com/content/early/2020/09/08/gutjnl-2020-320990
Gut Chapelle N

Sep 27th, 2020 - This review evaluates the evidence across 80 meta-analyses of interventional and observational studies of CRC prevention using medications, vitamins, supplements and dietary factors.

Clinical Implications of First-Line Pembro for MSI-High mCRC
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200220/full/

Jun 23rd, 2020 - Long-awaited results from the randomized, phase III KEYNOTE-177 trial provide strong support for using single-agent pembrolizumab instead of a chemotherapy-based regimen in patients newly diagnosed with metastatic colorectal cancer (mCRC) featurin...

Thierry André, MD, on Colorectal Cancer: Pembrolizumab vs Chemotherapy for Metastatic Disease
https://ascopost.com/videos/asco20-virtual-scientific-program/thierry-andre-on-pembrolizumab-vs-chemotherapy-for-metastatic-colorectal-cancer/

May 31st, 2020 - Thierry André, MD, of Hôpital Saint-Antoine, discusses the phase III results from KEYNOTE-177, which showed that, compared with standard chemotherapy of FOLFOX or FOLFIRI, pembrolizumab doubled median progression-free survival, from 8.2 months to...

see more →

Drugs  215 results see all →

Clinicaltrials.gov  81,557 results

Albumin-stabilized layered double hydroxide nanoparticles synergised combination chemot...
https://doi.org/10.1016/j.nano.2021.102369
Nanomedicine : Nanotechnology, Biology, and Medicine; Li L, Qian Y et. al.

Feb 26th, 2021 - Combination chemotherapy with two or more complimentary drugs has been widely used for clinical cancer treatment. However, the efficacy and side effects of combination chemotherapy still remains a challenge. Here, we constructed an albumin-stabili...

Sarcopenic obesity is a postoperative prognostic factor for stage II and III colorectal...
https://doi.org/10.1007/s11605-021-04965-8 10.1097/SLA.0000000000002555 10.1245/s10434-017-6077-y 10.1016/j.nut.2016.04.003 10.2169/internalmedicine.50.5474 10.1007/s10620-018-5019-2
Journal of Gastrointestinal Surgery : Official Journal Of... Mizuno S, Seishima R et. al.

Feb 26th, 2021 - Sarcopenic obesity is a postoperative prognostic factor for stage II and III colorectal cancer.|2021|Mizuno S,Seishima R,Okabayashi K,Shigeta K,Matsui S,|

see more →

News  3,949 results

No Survival Benefit to Primary Resection Before Chemo in Metastatic Colorectal Cancer
https://www.medscape.com/viewarticle/946506

Feb 25th, 2021 - NEW YORK (Reuters Health) - Contrary to previous reports, primary tumor resection prior to chemotherapy did not confer a survival benefit in colorectal cancer patients in a randomized phase 3 study in Japan. "I was surprised by the findings becaus...

Drive-by 'FluFIT' Clinics May Boost CRC Screening During COVID Pandemic
https://www.medscape.com/viewarticle/945573

Feb 10th, 2021 - NEW YORK (Reuters Health) - Drive-by clinics that offer fecal immunochemical tests (FIT) may be a good way to boost colorectal cancer (CRC) screening during the COVID-19 pandemic, according to results of a new pilot study. The research, presented ...

Lung Transplant Recipients at Heightened Risk of Colorectal Polyps
https://www.medscape.com/viewarticle/945253

Feb 3rd, 2021 - NEW YORK (Reuters Health) - Lung transplant patients are at increased risk of developing colorectal adenomas in the first few years after transplantation, possibly warranting enhanced surveillance for colorectal cancer (CRC), a new study suggests....

Breast Cancer Overtakes Lung as Most Common Cancer-WHO
https://www.medscape.com/viewarticle/945119

Feb 3rd, 2021 - GENEVA (Reuters) - Breast cancer has overtaken lung cancer as the most common form of the disease, accounting for nearly 12% of new cases each year worldwide, the World Health Organisation said on Tuesday. "For the first time, breast cancer now co...

Jury's Still Out on Trifluridine/Tipiracil Plus Bev in mCRC
https://www.medscape.com/viewarticle/944927

Jan 28th, 2021 - First-line trifluridine/tipiracil plus bevacizumab (TT-B) offered a slight survival benefit over capecitabine plus bevacizumab (C-B) in patients with unresectable metastatic colorectal cancer in the final analysis of the TASCO1 trial. The median p...

see more →

Patient Education  53 results see all →